These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25707713)

  • 1. Cannabinoids & Stress: impact of HU-210 on behavioral tests of anxiety in acutely stressed mice.
    Kinden R; Zhang X
    Behav Brain Res; 2015 May; 284():225-30. PubMed ID: 25707713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of anxiety-like responsiveness to the cannabinoid CB(1) receptor agonist HU-210 following chronic stress.
    Hill MN; Gorzalka BB
    Eur J Pharmacol; 2004 Sep; 499(3):291-5. PubMed ID: 15381051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.
    Keenan CM; Storr MA; Thakur GA; Wood JT; Wager-Miller J; Straiker A; Eno MR; Nikas SP; Bashashati M; Hu H; Mackie K; Makriyannis A; Sharkey KA
    Br J Pharmacol; 2015 May; 172(9):2406-18. PubMed ID: 25572435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased sensitivity to restraint stress and novelty-induced emotionality following long-term, high dose cannabinoid exposure.
    Hill MN; Gorzalka BB
    Psychoneuroendocrinology; 2006 May; 31(4):526-36. PubMed ID: 16442741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex, drugs, and adult neurogenesis: sex-dependent effects of escalating adolescent cannabinoid exposure on adult hippocampal neurogenesis, stress reactivity, and amphetamine sensitization.
    Lee TT; Wainwright SR; Hill MN; Galea LA; Gorzalka BB
    Hippocampus; 2014 Mar; 24(3):280-92. PubMed ID: 24132958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous and synthetic cannabinoids induce the downregulation of cannabinoid CB1 receptor in retina.
    Papadogkonaki S; Theodorakis Κ; Thermos K
    Exp Eye Res; 2019 Aug; 185():107694. PubMed ID: 31199905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic deletion of dopamine D1 receptors increases the sensitivity to cannabinoid CB1 receptor antagonist-precipitated withdrawal when compared with wild-type littermates: studies in female mice repeatedly exposed to the Spice cannabinoid HU-210.
    Serrano A; Vadas E; Ferrer B; Bilbao A; Granado N; Suárez J; Pavon FJ; Moratalla R; Rodríguez de Fonseca F
    Psychopharmacology (Berl); 2021 Feb; 238(2):551-557. PubMed ID: 33410990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CB1 receptor is required for the establishment of the hyperlocomotor phenotype in developmentally-induced hypothyroidism in mice.
    Giné E; Echeverry-Alzate V; Lopez-Moreno JA; Rodriguez de Fonseca F; Perez-Castillo A; Santos A
    Neuropharmacology; 2017 Apr; 116():132-141. PubMed ID: 28017790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment with curcumin attenuates anxiety while strengthens memory performance after one short stress experience in male rats.
    Haider S; Naqvi F; Batool Z; Tabassum S; Sadir S; Liaquat L; Naqvi F; Zuberi NA; Shakeel H; Perveen T
    Brain Res Bull; 2015 Jun; 115():1-8. PubMed ID: 25869755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locomotor effects of morphine or alcohol in mice after a repeated treatment with the cannabinoid agonist HU 210.
    Hagues G; Costentin J; Duterte-Boucher D
    Eur J Pharmacol; 2008 May; 586(1-3):197-204. PubMed ID: 18400220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
    J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior.
    Farinha-Ferreira M; Rei N; Fonseca-Gomes J; Miranda-Lourenço C; Serrão P; Vaz SH; Gomes JI; Martins V; de Alves Pereira B; Sebastião AM
    Neuropharmacology; 2022 Aug; 214():109155. PubMed ID: 35660545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat.
    Abalo R; Chen C; Vera G; Fichna J; Thakur GA; López-Pérez AE; Makriyannis A; Martín-Fontelles MI; Storr M
    Neurogastroenterol Motil; 2015 Dec; 27(12):1721-35. PubMed ID: 26387676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour.
    Rubino T; Guidali C; Vigano D; Realini N; Valenti M; Massi P; Parolaro D
    Neuropharmacology; 2008 Jan; 54(1):151-60. PubMed ID: 17692344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural effects of quinpirole following withdrawal of chronic treatment with the CB1 agonist, HU-210, in rats.
    Moreno M; Lopez-Moreno JA; Rodríguez de Fonseca F; Navarro M
    Behav Pharmacol; 2005 Sep; 16(5-6):441-6. PubMed ID: 16148449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cannabinoid agonist HU 210 modifies rat behavioural responses to novelty and stress.
    Giuliani D; Ferrari F; Ottani A
    Pharmacol Res; 2000 Jan; 41(1):47-53. PubMed ID: 10600269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect.
    McLaughlin RJ; Hill MN; Morrish AC; Gorzalka BB
    Behav Pharmacol; 2007 Sep; 18(5-6):431-8. PubMed ID: 17762511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids, interoception, and anxiety.
    Andrade AK; Renda B; Murray JE
    Pharmacol Biochem Behav; 2019 May; 180():60-73. PubMed ID: 30922834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo.
    Bosier B; Muccioli GG; Mertens B; Sarre S; Michotte Y; Lambert DM; Hermans E
    Neuropharmacology; 2012 Jun; 62(7):2328-36. PubMed ID: 22365976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behaviour.
    Grey J; Terry P; Higgs S
    Behav Pharmacol; 2012 Sep; 23(5-6):551-9. PubMed ID: 22772336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.